A Dynamical Systems Perspective on Chimeric Antigen Receptor T-Cell Dosing
Chimeric antigen receptor T cells (CAR T cells) are dosed similarly to donor lymphocyte infusions following hematopoietic cell transplantation. In this perspective paper a mathematical basis for personalized dosing of CAR T cells is introduced.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings
Chimeric antigen receptor (CAR) T-cell based immunotherapy has shown its potential in treating blood cancers, and its application to solid tumors is currently being extensively investigated. For glioma brain tumors, vari…
Mathematical Modeling Insights into Improving CAR T cell Therapy for Solid Tumors: Antigen Heterogeneity and Bystander Effects
As an adoptive cellular therapy, Chimeric Antigen Receptor T-cell (CAR T-cell) therapy has shown remarkable success in hematological malignancies, but only limited efficacy against solid tumors. Compared with blood cance…
Control-Oriented Models Inform Synthetic Biology Strategies in CAR T Cell Immunotherapy
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment of blood cancers. Mathematical models that can predict the effectiveness of immunotherapies such as CAR T are of increasing interest due to …
A dynamical model of the adaptive immune system: effects of cells promiscuity, antigens and B-B interactions
We analyse a minimal model for the primary response in the adaptive immune system comprising three different players: antigens, T and B cells. We assume B-T interactions to be diluted and sampled locally from heterogeneo…
Simulating the Evolution of Signaling Signatures during CART-Cell -- Tumor Cell Interactions
Immunotherapies have been proven to have significant therapeutic efficacy in the treatment of cancer. The last decade has seen adoptive cell therapies, such as chimeric antigen receptor T-cell (CART-cell) therapy, gain F…